TER.NASDAQTeradyne, INC

Form 4: Teradyne Director Mercedes Johnson Sells 625 Shares of Common Stock

Sentiment:

SEC Form 4


Director Mercedes Johnson sold 625 shares of Teradyne (TER) common stock at a price of $111.42 per share on November 7, 2024, according to a Form 4 filing with the SEC.

Summary

  • On November 7, 2024, Mercedes Johnson, a director of Teradyne, Inc. (TER), sold 625 shares of common stock.
  • The sale was executed at a price of $111.42 per share.
  • Following the transaction, Johnson directly owns 15,268 shares of Teradyne common stock.
  • The sale was conducted under a pre-arranged sales plan adopted on February 1, 2024, designed to comply with Rule 10b5-1.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.

Industry Context

This is a routine disclosure of an insider stock sale. It's common for executives and directors to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of insider trading. The sale itself is unlikely to have a significant impact on Teradyne's stock price unless it signals a broader trend of insider selling.

Stakeholder Impact

  • The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

DateDescription
February 1, 2024Date the reporting person adopted the sales plan.
November 7, 2024Date of the transaction (stock sale).
November 12, 2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.